American Financial Advisors LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

American Financial Advisors LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,253 shares of the exchange traded fund’s stock after selling 4,352 shares during the period. American Financial Advisors LLC owned approximately 0.06% of SPDR S&P Biotech ETF worth $4,346,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $141,284,000. Mirae Asset Securities USA Inc. boosted its position in shares of SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares in the last quarter. Assetmark Inc. grew its stake in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares during the last quarter. Finally, Whittier Trust Co. grew its stake in SPDR S&P Biotech ETF by 3.3% during the 3rd quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock worth $30,729,000 after buying an additional 9,976 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $91.41 on Friday. The stock has a market cap of $6.97 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average of $91.77 and a two-hundred day moving average of $96.13. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.